Helicobacter pylori eradication therapy and clinical outcomes in Parkinson's disease: a double-blind randomized placebo-controlled trial. | ClinicLens
Helicobacter pylori (HP) infection has been implicated in modifying treatment response and clinical outcomes in Parkinson's disease(PD). This study aimed to evaluate the effect of HP eradication therapy on motor symptoms, non-motor symptom burden, and quality of life in pati
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.